In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Magdalena Radović"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0002-3972-313X Pavle Sitarica"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0009-0006-4209-0640 Dragana Stanković"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0001-7669-2865 Marija Mirković"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0002-3176-5554 Drina Janković"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0003-3938-2790 Miloš Marić"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0009-0007-0110-7482 Marko Perić"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0001-8094-8464 Sanja Vranješ-Đurić"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0002-6340-2387 Aleksandar Vukadinović"VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.ORCID 0000-0002-9352-8036 Funding
bilateral Serbia-NR China project 003417078 2024 013440 003 000 620 021Ministry of Science, Technological Development, and Innovation of the Republic of Serbia 451-03-33/2026-03/ 200017Science Fund of the Republic of Serbia 7282
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
[161Tb]Tb-bisphosphonatesbiodistributionbone-targetingBPAMDDFThydroxyapatite binding
Identifiers
PMID41900797
PMCPMC13029369
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390